Intelligence · Clinical pipeline
Oncology R&D Pipeline
Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.
Quick answer
Oncology: NovaPharmaNews indexes 5,539 oncology clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.
Top sponsors
- First People's Hospital 474 programs
- Chinese Academy of 400 programs
- United Therapeutics Europe 219 programs
- George Institute for 172 programs
- Takeda 163 programs
- HOFFMANN-LA ROCHE 144 programs
- AstraZeneca 143 programs
- MSD Merck Sharp 131 programs
- Regeneron UK 128 programs
- Anaxis Pharma 125 programs
- Telethon Foundation 113 programs
- Novartis India 110 programs
Pipeline programs
-
Chemotherapy plus apatinib
Lei Li
Recurrent Cervical Carcinoma
1 trial -
Chemotherapy+PD-1 inhibitor+8Gy x 3f
Xiyuan Hospital of China Academy of Chinese Medical Sciences
HR+HER2- Breast Cancer
1 trial -
Chidamide
Sun Yat-sen University
Peripheral T-cell Lymphoma
1 trial -
Chidamide
Biotech Pharmaceutical Co.,
Hepatocellular Carcinoma (HCC)
1 trial -
Chidamide
The First People's Hospital of Lianyungang
Neuroendocrine Tumors
2 trials -
Chidamide
Biotech Pharmaceutical Co.,
Relapsed or Refractory Peripheral T-cell Lymphoma
1 trial -
Chidamide + Tislelizumab + chemotherapy (CapeOX )
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colon Adenocarcinoma
1 trial -
Chidamide combined with Duvillisib
The First People's Hospital of Lianyungang
Peripheral T Cell Lymphoma
1 trial -
Chinese Medicine Oral Rinse Formula-I (CMORF-I)
Chinese University of Hong Kong
Head and Neck Neoplasms
1 trial -
Chlorambucil
Teva Pharma GmbH
Chronic Lymphocytic Leukemia
1 trial -
Cholecalciferol
Hospital Authority, Hong Kong
Hematologic Neoplasms
1 trial -
Cisplatin
Ultragenyx UK Limited
Squamous Cell Carcinoma of the Anus
1 trial -
Cisplatin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cervical Cancer
1 trial -
Cisplatin Accord Healthcare /ml concentraat v... for Vulvar cancer
Disc Medicine
Vulvar cancer
1 trial -
Cisplatin and Doxorubicin
Chinese University of Hong Kong
Gastric Cancer Peritoneal Metastases
1 trial -
Cisplatin+Capecitabine+Sintilimab
The First People's Hospital of Lianyungang
Esophageal Squamous Cell Carcinoma
1 trial -
Clifutinib Besylate
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Acute Myeloid Leukemia, Adult
1 trial -
Clobetasol Propionate
United Therapeutics Europe Ltd
Colon Adenocarcinoma
1 trial -
Clostridium Butyricum Tablets
The First People's Hospital of Lianyungang
Bladder (Urothelial, Transitional Cell) Cancer
1 trial -
Cobimetinib
Hoffmann-La Roche
Solid Tumors
1 trial -
Colonoscopy with enhanced dye
Cardiff Oncology
Colorectal Cancer
1 trial -
Combination of MK3475 with Metronomic CP
Lxo Ireland Designated Activity Company
Sarcoma
1 trial -
Combination of Palbociclib and aromatase inhibitor (Letrozole or Anastrozole)
United Therapeutics Europe Ltd
Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer
1 trial -
Combination therapy (COMB)
The First People's Hospital of Lianyungang
Esophageal Squamous Cell Carcinoma (ESCC)
1 trial -
Combinations
The First People's Hospital of Lianyungang
Colorectal Cancer
1 trial -
Conventional Roux-en-Y Gastrojejunostomy
The First People's Hospital of Lianyungang
Gastric Cancer
1 trial -
Coriolus Versicolor
Hospital Authority, Hong Kong
Carcinoma
1 trial -
Cotellic 20 mg film-coated tablets, Ginisortamab
Ningbo Cancer Hospital
Metastatic pancreatic ductal adenocarcinoma
1 trial -
Cretostimogene Grenadenorepvec
CG Oncology
High-Risk Non-Muscle-Invasive Bladder Cancer
1 trial -
Cyclophosphamide
Iovance Biotherapeutics B.V.
Clinical Stage IV Cutaneous Melanoma AJCC v8
1 trial -
Cyclophosphamide
United Therapeutics Europe Ltd
Metastatic Melanoma
1 trial -
Cyclophosphamide
ADC Therapeutics SA
Double-Expressor Lymphoma
1 trial -
Cyclophosphamide
Takeda
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
1 trial -
Cyclophosphamide
The First People's Hospital of Lianyungang
Acute Lymphoblastic Leukemia, Pediatric
1 trial -
Cyclophosphamide
BEONE MEDICINES AUS PTY LTD
Recurrent Transformed Chronic Lymphocytic Leukemia
1 trial -
Cyclophosphamide
Iovance Biotherapeutics B.V.
Metastatic Bladder Urothelial Carcinoma
1 trial -
Cyclophosphamide Doxorubicin Vincristine Lamivudine
Taiwan Liposome Company
Non-Hodgkin's Lymphoma
1 trial -
Cyclophosphamide+Pemetrexed+5-Fluorouracil
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Locally Advanced Thyroid Gland Carcinoma
1 trial -
Cyproterone acetate 5
Teva Pharma GmbH
Prostate Cancer
1 trial -
Cyramza /ml concentrate for stomach cancer stage IV with me…
CERO THERAPEUTICS HOLDINGS, INC.
stomach cancer stage IV with metastases
1 trial -
Cytarabine
Jazz Pharmaceuticals Ireland Limited
Leukemia
1 trial -
Cytarabine
Teva Pharma GmbH
Acute Myeloid Leukemia
1 trial -
Cytarabine
Kura Oncology
Acute Myeloid Leukemia
1 trial -
Cytarabine and Idarubicin
Jazz Pharmaceuticals Ireland Limited
Acute Myeloid Leukemia
1 trial -
Cytokine-induced killer cells
The First People's Hospital of Lianyungang
Ovarian Carcinoma
1 trial -
Cytokine-induced killer cells
The First People's Hospital of Lianyungang
Melanoma
1 trial -
D20181321
Pari Pharma GmbH
recurrent primary supratentorial malignant brain tumors in children
1 trial -
D361FC00001
AstraZeneca AB
Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
1 trial
Frequently asked questions
How many oncology pipeline programs are tracked?
5,539 programs match this therapeutic area based on indication text, program name, and registry metadata.
Where does pipeline data come from?
ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.